During the past decade, ENT and Allergy Associates of Florida conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "ENT and Allergy Associates of Florida" are "Chronic Tympanic Membrane Perforation" (1 trials), "Meniere Disease" (1 trials), "Ménière" (1 trials), "Sensorineural Hearing Loss" (1 trials) and "Septoplasty" (1 trials). Many other conditions were trialed in "ENT and Allergy Associates of Florida" in a lesser frequency.

Most popular intervention types in "ENT and Allergy Associates of Florida" are "Drug" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "ASP0598" (1 trials), "ENTACT Septal Staple system" (1 trials), "Ebselen" (1 trials) and "Matching Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "ENT and Allergy Associates of Florida" are 4 trials for "All" genders.

Currently, there are NaN active trials in "ENT and Allergy Associates of Florida". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in ENT and Allergy Associates of Florida, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in ENT and Allergy Associates of Florida, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".